Our results indicated that several compounds, including c‐Myc‐i7, c‐Myc‐i8, and c‐Myc‐i10, exhibited remarkable reductions in cell viability across various cancer types, including lung, pancreatic, prostate, and breast cancers. Here, MYC is linked to cancer.